A new method for assessment of an anti-5HT(2A) agent, sarpogrelate hydrochloride, on platelet aggregation.
Satoh
K
K
Yatomi
Y
Y
Ozaki
Y
Y
D001120:Arginine / Q000031:analogs & derivatives; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D010875:Pipecolic Acids / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D010979:Platelet Function Tests / Q000379:methods*; D012701:Serotonin / Q000494:pharmacology; D058830:Serotonin 5-HT2 Receptor Antagonists; D012702:Serotonin Antagonists / Q000494:pharmacology*; D013386:Succinates / Q000494:pharmacology*; D013449:Sulfonamides
D010875:Pipecolic Acids; D010975:Platelet Aggregation Inhibitors; D058830:Serotonin 5-HT2 Receptor Antagonists; D012702:Serotonin Antagonists; D013386:Succinates; D013449:Sulfonamides; C064294:sarpogrelate; D012701:Serotonin; D001120:Arginine; C031942:argatroban; D004837:Epinephrine